BIOMENDEX
Biomendex develops and manufactures adaptable synthetic bone substitute materials for bone regeneration. Their invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Adaptos® bone graft substitutes are being developed for clinical and veterinary use.
BIOMENDEX
Industry:
Biotechnology Health Care Manufacturing
Founded:
2018-01-01
Address:
Tampere, Western Finland, Finland
Country:
Finland
Website Url:
http://www.biomendex.com
Total Employee:
1+
Status:
Active
Total Funding:
2.25 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
Cerus
Cerus is a biomedical products company focused in the field of blood safety.
CoreBone
CoreBone is a bioactive coral-based bone graft substitute material.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - Biomendex
Official Site Inspections
http://www.biomendex.com
- Host name: 255.56.88.34.bc.googleusercontent.com
- IP address: 34.88.56.255
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biomendex"
Biomendex – Next-level tissue regeneration
Adaptos ® Vet is Biomendex’s highly competitive adaptable bone graft substitute product line for veterinarians. We are currently open for new distributor proposals especially in Europe. If you have the industry experience and insight, great …See details»
Biomendex – Who we are and what we stand for.
Biomendex also works to enhance tissue technology and manufactures superior medical devices. We aim to resolve various problems in the fields of oral and maxillofacial surgery, orthopedic surgery, sports surgery, soft tissue surgery, …See details»
Biomendex - Crunchbase Company Profile & Funding
Biomendex develops and manufactures adaptable synthetic bone substitute materials for bone regeneration. Their invention, Adaptos®, is the first …See details»
Biomendex 2025 Company Profile: Valuation, Funding & Investors
Biomendex General Information Description. Developer of adaptable synthetic bone substitute materials designed to be used for bone regeneration. The company's materials are made of …See details»
Biomendex Oy Company Profile | TAMPERE, Pirkanmaa, Finland ...
Find company research, competitor information, contact details & financial data for Biomendex Oy of TAMPERE, Pirkanmaa. Get the latest business insights from Dun & Bradstreet.See details»
Biomendex - Products, Competitors, Financials, Employees, …
Biomendex is a company focused on next-level tissue regeneration within the medical device industry. They specialize in the development and manufacture of adaptable synthetic bone …See details»
Biomendex Company Profile - Office Locations, Competitors
Biomendex has 5 employees at their 1 location. See insights on Biomendex including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Biomendex - Funding, Financials, Valuation & Investors - Crunchbase
Organization. Biomendex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... obfuscated. in funding over 1 round. This was a Grant …See details»
Biomendex is throwing more than a bone to orthopaedists - Good …
Tampere-based Biomendex has developed a more convenient and less risky alternative to bone grafts. A rather unusual pet project has evolved into a full-time undertaking for Kaarlo …See details»
BIOMENDEX OY - VentureRadar
Oct 1, 2019 Title: ADAPTOS - Changing the way bone voids are treated (Acronym: ADAPTOS) | Total Cost: €3212500 / EU contribution: €2248750 | Start: 2019-10-01 End: 2021-09-30See details»
Biomendex Oy - Drug pipelines, Patents, Clinical trials - Synapse
Mar 7, 2025 100 Translational Medicine associated with Biomendex Oy. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full …See details»
Biomendex – Superior adaptable bone grafts
Biomendex follows ISO14155:2020 when carrying out clinical studies. Data provided by clinical investigations plays an essential role in clinical evaluation to demonstrate safety and efficacy …See details»
Biomendex - Overview, News & Similar companies | ZoomInfo.com
Who is Biomendex. We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos™, is the first bioactive bone …See details»
Biomendex - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Biomendex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 18. Monthly Visits 429. …See details»
Biomendex announces collaboration with Mayo Clinic
Posted on 29.10.2024 by Biomendex. Share: We’re excited to announce our collaboration with Mayo Clinic to further develop our fully synthetic and biodegradable bone graft material, …See details»
Biomendex - Overview, News & Similar companies | ZoomInfo.com
Who is Biomendex. We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos, is the first b ioactive bone …See details»
Biomendex Company Profile - Life Science Intelligence
The United States Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United States. Understand trends in procedure volume …See details»
Biomendex enters into collaboration with Mayo Clinic
Currently, Biomendex is undergoing the FDA approval process for Adaptos® within the spinal surgery segment in the United States. Through a recently executed know-how agreement, …See details»
Biomendex – Groundbreaking technology behind Adaptos®
The use of Adaptos ® bone graft substitute reduces the need for autologous bone grafting, which leads to decreased surgery time as well as fewer complications. It also improves current …See details»
Biomendex Enters Collaboration with Mayo Clinic | ORTHOWORLD
Oct 30, 2024 Biomendex is continuing the development of its fully synthetic and biodegradable bone graft material, Adaptos, to enable better outcomes for patients and surgeons. Currently, …See details»